MeiraGTx Holdings (MGTX) Capital Expenditures (QoQ) (2017 - 2025)
MeiraGTx Holdings (MGTX) Capital Expenditures (QoQ) (2017 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | MeiraGTx Holdings | 973.21 Mn | 907.27 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -55.41% |
| Sep 30, 2025 | -50.57% |
| Jun 30, 2025 | -27.84% |
| Mar 31, 2025 | 40.39% |
| Dec 31, 2024 | 66.85% |
| Sep 30, 2024 | -79.94% |
| Jun 30, 2024 | 675.79% |
| Mar 31, 2024 | -135.23% |
| Dec 31, 2023 | 113.23% |
| Sep 30, 2023 | -372.66% |
| Jun 30, 2023 | -42.18% |
| Mar 31, 2023 | -80.81% |
| Dec 31, 2022 | 270.22% |
| Sep 30, 2022 | -288.21% |
| Jun 30, 2022 | 12.36% |
| Mar 31, 2022 | -48.87% |
| Dec 31, 2021 | 104.70% |
| Sep 30, 2021 | 113.54% |
| Jun 30, 2021 | 23.83% |
| Mar 31, 2021 | -43.83% |